Skip to main content
OpenTrials

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

9,012 public trials 1,844 recruiting studies
Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Active, not recruiting

A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03934567

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • China-Japan Friendship Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
  • Jilin Cancer Hospital Changchun, China
View all 26 locations
View Trial Details
Active, not recruiting

A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients

NCT04024696

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
  • Zhejiang Cancer Hospital Hangzhou, China
  • Tianjin Medical University General Hospital Tianjin, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, China
View Trial Details
Active, not recruiting

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03600441

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Advocate Medical Group - Park Ridge, Luther Lane - Oncology Park Ridge, Illinois, United States
  • Norton Cancer Institute - St. Matthews Campus Louisville, Kentucky, United States
  • Clinical Research Alliance Inc Lake Success, New York, United States
  • Manhattan Hematology Oncology Center New York, United States
View all 15 locations
View Trial Details
Active, not recruiting

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

NCT05206357

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Lucile Packard Children's Hospital /ID# 240854 Palo Alto, California, United States
  • Nicklaus Children's Hospital /ID# 241174 Miami, Florida, United States
  • New York Medical College /ID# 239208 Valhalla, New York, United States
  • Levine Children's Hospital /ID# 242765 Charlotte, North Carolina, United States
View all 41 locations
View Trial Details
Active, not recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

NCT04233346

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details
Active, not recruiting

Effectiveness of Methotrexate Versus Prednisone as First-line Therapy for Pulmonary Sarcoidosis

NCT04314193

Conditions
Hemic and Lymphatic Diseases, Hypersensitivity, Hypersensitivity, Delayed, +8 more
Locations
  • Jeroen Bosch Ziekenhuis 's-Hertogenbosch, Netherlands
  • Vrije Universiteit Medisch Centrum Amsterdam, Netherlands
  • Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands
  • Academisch Medisch Centrum Amsterdam, Netherlands
View all 17 locations
View Trial Details

Related conditions